Welcome!

News Feed Item

Coronary Vasospasm Global Clinical Trials Review, H2, 2014

LONDON, Sept. 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Coronary Vasospasm Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/648928/Coronary-Vasospasm-Global-Clinical-Trials-Review-H2-2014.html

Coronary Vasospasm Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Coronary Vasospasm Global Clinical Trials Review, H2, 2014" provides data on the Coronary Vasospasm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Vasospasm. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Coronary Vasospasm. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Coronary Vasospasm 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Coronary Vasospasm 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Coronary Vasospasm Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Pfizer Inc. 27
Clinical Trial Overview of Pfizer Inc. 27
Clinical Trial Overview of Top Institutes / Government 28
Japanese Coronary Spasm Association 28
Clinical Trial Overview of Japanese Coronary Spasm Association 28
Robert Bosch Medical Center 29
Clinical Trial Overview of Robert Bosch Medical Center 29
Kyorin University 30
Clinical Trial Overview of Kyorin University 30
Kumamoto University 31
Clinical Trial Overview of Kumamoto University 31
National Institute of Health and Medical Research 32
Clinical Trial Overview of National Institute of Health and Medical Research 32
University of Nebraska 33
Clinical Trial Overview of University of Nebraska 33
Korea University 34
Clinical Trial Overview of Korea University 34
University Hospital Basel 35
Clinical Trial Overview of University Hospital Basel 35
Washington University School of Medicine 36
Clinical Trial Overview of Washington University School of Medicine 36
University of California, San Francisco 37
Clinical Trial Overview of University of California, San Francisco 37
Five Key Clinical Profiles 38
Appendix 55
Abbreviations 55
Definitions 55
Research Methodology 56
Secondary Research 56
About GlobalData 57
Contact Us 57
Disclaimer 57
Source 57

List of Tables
Coronary Vasospasm Therapeutics, Global, Clinical Trials by Region, 2014* 6
Coronary Vasospasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Coronary Vasospasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Coronary Vasospasm Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Coronary Vasospasm Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Coronary Vasospasm Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Coronary Vasospasm Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 12
Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 13
Coronary Vasospasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Coronary Vasospasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 16
Coronary Vasospasm Therapeutics, Global, Clinical Trials by Phase, 2014* 17
Coronary Vasospasm Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 18
Coronary Vasospasm Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Coronary Vasospasm Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Coronary Vasospasm Therapeutics, Global, Suspended Clinical Trials, 2014* 21
Coronary Vasospasm Therapeutics, Global, Withdrawn Clinical Trials, 2014* 21
Coronary Vasospasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Coronary Vasospasm Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Coronary Vasospasm Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Coronary Vasospasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Coronary Vasospasm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 27
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Japanese Coronary Spasm Association, 2014* 28
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Robert Bosch Medical Center, 2014* 29
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyorin University, 2014* 30
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Kumamoto University, 2014* 31
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Health and Medical Research, 2014* 32
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2014* 33
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Korea University, 2014* 34
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014* 35
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 36
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 37

List of Figures
Coronary Vasospasm Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Coronary Vasospasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Coronary Vasospasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Coronary Vasospasm Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Coronary Vasospasm Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Coronary Vasospasm Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 13
Coronary Vasospasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Coronary Vasospasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 16
Coronary Vasospasm Therapeutics, Global, Clinical Trials by Phase (%), 2014* 17
Coronary Vasospasm Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 18
Coronary Vasospasm Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Coronary Vasospasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Coronary Vasospasm Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Coronary Vasospasm Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
GlobalData Methodology 56

Read the full report:
Coronary Vasospasm Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/648928/Coronary-Vasospasm-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
"There's plenty of bandwidth out there but it's never in the right place. So what Cedexis does is uses data to work out the best pathways to get data from the origin to the person who wants to get it," explained Simon Jones, Evangelist and Head of Marketing at Cedexis, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
In his session at 21st Cloud Expo, Carl J. Levine, Senior Technical Evangelist for NS1, will objectively discuss how DNS is used to solve Digital Transformation challenges in large SaaS applications, CDNs, AdTech platforms, and other demanding use cases. Carl J. Levine is the Senior Technical Evangelist for NS1. A veteran of the Internet Infrastructure space, he has over a decade of experience with startups, networking protocols and Internet infrastructure, combined with the unique ability to it...
SYS-CON Events announced today that CrowdReviews.com has been named “Media Sponsor” of SYS-CON's 22nd International Cloud Expo, which will take place on June 5–7, 2018, at the Javits Center in New York City, NY. CrowdReviews.com is a transparent online platform for determining which products and services are the best based on the opinion of the crowd. The crowd consists of Internet users that have experienced products and services first-hand and have an interest in letting other potential buye...
Agile has finally jumped the technology shark, expanding outside the software world. Enterprises are now increasingly adopting Agile practices across their organizations in order to successfully navigate the disruptive waters that threaten to drown them. In our quest for establishing change as a core competency in our organizations, this business-centric notion of Agile is an essential component of Agile Digital Transformation. In the years since the publication of the Agile Manifesto, the conn...
Enterprises are moving to the cloud faster than most of us in security expected. CIOs are going from 0 to 100 in cloud adoption and leaving security teams in the dust. Once cloud is part of an enterprise stack, it’s unclear who has responsibility for the protection of applications, services, and data. When cloud breaches occur, whether active compromise or a publicly accessible database, the blame must fall on both service providers and users. In his session at 21st Cloud Expo, Ben Johnson, C...
"We're developing a software that is based on the cloud environment and we are providing those services to corporations and the general public," explained Seungmin Kim, CEO/CTO of SM Systems Inc., in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Enterprises are adopting Kubernetes to accelerate the development and the delivery of cloud-native applications. However, sharing a Kubernetes cluster between members of the same team can be challenging. And, sharing clusters across multiple teams is even harder. Kubernetes offers several constructs to help implement segmentation and isolation. However, these primitives can be complex to understand and apply. As a result, it’s becoming common for enterprises to end up with several clusters. Thi...
"MobiDev is a software development company and we do complex, custom software development for everybody from entrepreneurs to large enterprises," explained Alan Winters, U.S. Head of Business Development at MobiDev, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Data scientists must access high-performance computing resources across a wide-area network. To achieve cloud-based HPC visualization, researchers must transfer datasets and visualization results efficiently. HPC clusters now compute GPU-accelerated visualization in the cloud cluster. To efficiently display results remotely, a high-performance, low-latency protocol transfers the display from the cluster to a remote desktop. Further, tools to easily mount remote datasets and efficiently transfer...
"Codigm is based on the cloud and we are here to explore marketing opportunities in America. Our mission is to make an ecosystem of the SW environment that anyone can understand, learn, teach, and develop the SW on the cloud," explained Sung Tae Ryu, CEO of Codigm, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events announced today that Telecom Reseller has been named “Media Sponsor” of SYS-CON's 22nd International Cloud Expo, which will take place on June 5-7, 2018, at the Javits Center in New York, NY. Telecom Reseller reports on Unified Communications, UCaaS, BPaaS for enterprise and SMBs. They report extensively on both customer premises based solutions such as IP-PBX as well as cloud based and hosted platforms.
"CA has been doing a lot of things in the area of DevOps. Now we have a complete set of tool sets in order to enable customers to go all the way from planning to development to testing down to release into the operations," explained Aruna Ravichandran, Vice President of Global Marketing and Strategy at CA Technologies, in this SYS-CON.tv interview at DevOps Summit at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
WebRTC is great technology to build your own communication tools. It will be even more exciting experience it with advanced devices, such as a 360 Camera, 360 microphone, and a depth sensor camera. In his session at @ThingsExpo, Masashi Ganeko, a manager at INFOCOM Corporation, introduced two experimental projects from his team and what they learned from them. "Shotoku Tamago" uses the robot audition software HARK to track speakers in 360 video of a remote party. "Virtual Teleport" uses a multip...
In his session at 21st Cloud Expo, James Henry, Co-CEO/CTO of Calgary Scientific Inc., introduced you to the challenges, solutions and benefits of training AI systems to solve visual problems with an emphasis on improving AIs with continuous training in the field. He explored applications in several industries and discussed technologies that allow the deployment of advanced visualization solutions to the cloud.
"Infoblox does DNS, DHCP and IP address management for not only enterprise networks but cloud networks as well. Customers are looking for a single platform that can extend not only in their private enterprise environment but private cloud, public cloud, tracking all the IP space and everything that is going on in that environment," explained Steve Salo, Principal Systems Engineer at Infoblox, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Conventio...